| 1. |
Campo E, Brunier MN, Merino MJ. Small cell carcinoma of the endometrium with associated ocular paraneoplastic syndrome[J].Cancer, 1992, 69(9):2283-2288.
|
| 2. |
Ohkawa T, Kawashima H, Makino S, et al. Cancer-associated retinopathy in a patient with endometrial cancer[J]. Am J Ophthalmol, 1996, 122(5):740-742.
|
| 3. |
Sekiguchi I, Suzuki M, Sato I, et al. Rare case of small-cell carcinoma arising from the endometrium with paraneoplastic retinopathy[J]. Gynecol Oncol, 1998, 71(3):454-457.
|
| 4. |
Mohamed Q, Harper CA. Acute optical coherence tomographic findings in cancer-associated retinopathy[J]. Arch Ophthalmol, 2007, 125(8):1132-1133.
|
| 5. |
Lima LH, Greenberg JP, Greenstein VC, et al. Hyperautofluorescent ring in autoimmune retinopathy[J]. Retina, 2012, 32(7):1385-1394.
|
| 6. |
Otsuji F, Abematsu N, Nakao K, et al. A case of cancer-associated retinopathy rapidly leading to blindness with a unique pupillary light reflex[J]. Nihon Ganka Gakkai Zasshi, 2011, 115(10):924-929.
|
| 7. |
Anastasakis A, Dick AD, Damato EM, et al. Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction[J]. Doc Ophthalmol, 2011, 123(1):59-63.
|
| 8. |
Wang MY, Arnold AC, Vinters HV, et al. Bilateral blindness and lumbosacral myelopathy associated with high-dose carmustine and cisplatin therapy[J]. Am J Ophthalmol, 2000, 130(3):367-368.
|
| 9. |
Katz BJ, Ward JH, Digre KB, et al. Persistent severe visual and electroretinographic abnormalities after intravenous Cisplatin therapy[J]. J Neuroophthalmol, 2003, 23(2):132-135.
|
| 10. |
Kwan AS, Sahu A, Palexes G. Retinal ischemia with neovascularization in cisplatin related retinal toxicity[J].Am J Ophthalmol, 2006, 141(1):196-197.
|
| 11. |
Grewal DS, Fishman GA, Jampol LM. Autoimmune retinopathy and antiretinal antibodies:a review[J]. Retina, 2014, 34(5):827-845.
|
| 12. |
Huynh N, Shildkrot Y, Lobo AM, et al. Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy[J]. J Ophthalmic Inflamm Infect, 2012, 2(3):169-171.
|
| 13. |
Or C, Collins DR, Merkur AB, et al. Intravenous rituximab for the treatment of cancer-associated retinopathy[J]. Can J Ophthalmol, 2013, 48(2):35-38.
|
